Finance

Lists
Why is SNOA down 4,92%?
Dive Deeper
SNOA:NASDAQ
Sonoma Pharmaceuticals Inc
1,16 $
-4,92%
(-0,060) 1D
1,15 $
-0,86% (-0,0100)
After hours
Closed: 8 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNOA...
Open
1,20 $
High
1,20 $
Low
1,14 $
Mkt. cap
5,55 млн
Avg. vol.
51,13 мың
Volume
89,49 мың
52-wk high
4,40 $
52-wk low
0,85 $
EPS
-1,22 $
Beta
1,30
Shares outstanding
4,79 млн
No. of employees
260
Open
1,20 $
High
1,20 $
Low
1,14 $
Mkt. cap
5,55 млн
Avg. vol.
51,13 мың
Volume
89,49 мың
52-wk high
4,40 $
52-wk low
0,85 $
EPS
-1,22 $
Beta
1,30
Shares outstanding
4,79 млн
No. of employees
260
News stories
From web sources and news partners
About Sonoma Pharmaceuticals Inc
CEO-
Employees260
Founded1999
HeadquartersБоулдер, Колорадо, Америка Құрама Штаттары
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
5,60 млн
4,35 млн
5,56 млн
6,41 млн
Cost of goods sold
3,48 млн
2,70 млн
3,38 млн
3,83 млн
Cost of revenue
3,48 млн
2,70 млн
3,38 млн
3,83 млн
Research and development expenses
575,00 м.
557,00 м.
545,00 м.
597,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88 млн
1,77 млн
1,99 млн
2,02 млн
Operating expense
2,46 млн
2,33 млн
2,53 млн
2,62 млн
Total operating expenses
5,94 млн
5,03 млн
5,91 млн
6,45 млн
Operating income
-337,00 м.
-678,00 м.
-351,00 м.
-40,00 мың
Other non operating income
-394,00 м.
-271,00 м.
-1,59 млн
-
EBT including unusual items
-731,00 м.
-949,00 м.
-497,00 м.
-330,00 м.
EBT excluding unusual items
-731,00 м.
-949,00 м.
-497,00 м.
-330,00 м.
Income tax expense
-197,00 м.
-130,00 м.
84,00 мың
-
Effective tax rate
26,95%
13,70%
-16,90%
-
Other operating expenses
-
-
-
-
Net income
-534,00 м.
-819,00 м.
-581,00 м.
-330,00 м.
Net profit margin
-9,53%
-18,83%
-10,45%
-5,15%
Earnings per share
-
-0,48
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-301,00 м.
-644,00 м.
-318,00 м.
-8,00 мың
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары